Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 study

References

• Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003;42:1206-52
   Google Scholar
• 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92
   Google Scholar
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87
   Google Scholar
• Prophylaxis, diagnostics and treatment of arterial hypertension. Russian recommendations (second edition). Cardiovascular therapy and prophylaxis, appendix. 2004; p.20
   Google Scholar
• Barrier PA, Li JT, Jensen NM. Two words to improve physician–patient communication: what else?. Mayo Clin Proc 2003;78:211-14
   PubMed Web of Science ®Google Scholar
• Betancourt JR, Camilo JE, Green AR. Hypertension in multicultural and minority populations. Curr Hypertens Rep 1999;1:482-8
   PubMedGoogle Scholar
• Burnier M. Blood pressure control and the implementation of guidelines in clinical practice: can we fill the gap?. J Hypertens 2002;20:1251
   PubMed Web of Science ®Google Scholar
• Leape LL, Weisman JS, Schneider EC, et al. Adherence to practice guidelines: the role of specialty society guidelines. Am Heart J 2003;145:19-26
   PubMed Web of Science ®Google Scholar
• Hagemeister J, Schneider CA, Barabas S, et al. Hypertension guidelines and their limitations – the impact of physician's compliance as evaluated by guidelines awareness. J Hypertens 2001;19:2079-86
   PubMed Web of Science ®Google Scholar
• Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians. Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000;160:2281-6
   PubMed Web of Science ®Google Scholar
• Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005;165:1410-19
   PubMed Web of Science ®Google Scholar
• Fagard RH, Van den Enden M, Leeman M, et al. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002;20:1297-302
   PubMed Web of Science ®Google Scholar
• Ong KL, Cheung BMY, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 2007;49:69-75
   PubMed Web of Science ®Google Scholar
• Kobalava ZhD, Sklizkova LA, Kotovskaya YuV, et al. Apprehensions of arterial hypertension in elderly patients and real clinical approach in Russia (results of 1st stage of Russian Practical Research ARGUS). Kardiologiia 2001;11:16-28
   Google Scholar
• Kobalava ZhD, Kotovskaya YuV, Starostina EG, et al. on behalf of researchers of Russian Practical Research ARGUS-2. Problems of a physician–patient interaction and control of arterial hypertension in Russia. Main results of scientific–practical program ARGUS-2. Kardiologiia 2007;47(3):38-47
   PubMed Web of Science ®Google Scholar
• Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-44
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blockers diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97
   PubMed Web of Science ®Google Scholar
• Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. JAMA 1997;277:739-45
   PubMed Web of Science ®Google Scholar
• Psaty BM, Manolio TA, Smith NL, et al. Time trends in high blood pressure control and the use of antihypertensive medication in older adults. Arch Intern Med 2002;162:2325-32
   PubMed Web of Science ®Google Scholar
• Shalnova SA, Deev AD, Organov RG. Reasons influencing upon lethality because of cardiovascular diseases in Russian population. Cardiovascular therapy and prophylaxis. 2005;1:4-9
   Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-62
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39:S1-S246
   PubMed Web of Science ®Google Scholar
• Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-72
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000;36:594-9
   PubMed Web of Science ®Google Scholar
• Kostis JB, Wilson AC, Fredenberger RS, et al. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35
   PubMed Web of Science ®Google Scholar
• Moser M. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension. The argument for. J Clin Hypertens 2005;7:111-16
   Google Scholar
• Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007; 369:201-7
   PubMed Web of Science ®Google Scholar
• Kobalava ZhD, Kotovskaja YuV, Verewagina GN, et al. Tolerability and efficacy of retard form of indapamide in the treatment of hypertension in elderly patients (results of multicenter open non-comparative trial in Russian program ARGUS). Kardiologiia 2002;42(7):25-35
   PubMed Web of Science ®Google Scholar
• Ambrosioni E, Safar M, Degaute JP, et al. on behalf of the European study group. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomized double-blind controlled studies. J Hypertens 1998;16(11):1677-84
   Google Scholar
• Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomized double-blind studies. Drug Saf 2001;24(15):1155-65
   PubMed Web of Science ®Google Scholar
• Robinson DM, Wellington K. Indapamide sustained release. A review of its use in the treatment of hypertension. Drugs 2006;66(2):257-71
   PubMed Web of Science ®Google Scholar
• Sassard J, Bataillard A, McIntyre H. An overview of the pharmacology and clinical efficacy of indapamide sustained release. Fundam Clin Pharmacol 2005;19(6):637-45
   PubMed Web of Science ®Google Scholar
• Akram J, Sheikh UE, Mahmood M, et al. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study. Curr Med Res Opin 2007;23(12):2929-36
   PubMed Web of Science ®Google Scholar
• Marre M, Puig JG, Kokot F, et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR study. J Hypertens 2004;22:1613-22
   PubMed Web of Science ®Google Scholar
• Gosse P, Sheridan DJ, Zannad F, et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens 2000;18(10):1465-75
   PubMed Web of Science ®Google Scholar
• Baguet JP, Legallicier B, Auquier P, et al. Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clin Drug Invest 2007;27(11):735-53
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. New Engl J Med 2008;358(8):1887-98
   PubMedGoogle Scholar